Synonyms: SMP-114
Compound class:
Synthetic organic
Comment: Rimacalib (SMP-114) is an isoxazole derivative inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) [2], CAMKII being an established pharmacological target for chronic inflammatory pain [1], as well as being involved in modulating synaptic plasticity and learning and memory processes.
|
|
No information available. |
Summary of Clinical Use ![]() |
A Phase 2 clinical trial of SMP-114 in rheumatoid arthritis (RA; NCT00296257) was terminated. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
In RA SMP-114 is predicted to behave as a novel disease-modifying antirheumatic drug (DMARD), slowing joint destruction and disease progression. |